Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 2329-0358

Get your full text copy in PDF

Procalcitonina, New Indicator for Non-Viral Infections in Heart, Lung or Liver Transplant Patients.

S Hammer, P Fraunberger, B Meiser, M Stangl, D Seidel, C Hammer

Ann Transplant 1999; 4(2): 5-9

ID: 497446

PCT is a highly specific analyse which shows significJ1t diagnostic validities when non-viral infections are compared with rejection episodes. PCT discriminates inflammatory events such as rejec:tion or viral infections and non-viral infections including bacterial, fungal and protozoal infections. The half-life of PCT is 24 h indicating a cle< rly competent antibiotic treatment. PCT provides vital information early to clinicians and allows them to improve the management of bacteri.1l/fungal infection in immunocompromized transplant patients. PCT thus facilitates and improves the outcome of survival rate and the quality of life in the postoperative period of patients with heart, lung or liver grafts.

Keywords: procalcitonin, acute rejection, Infection, Transplantation

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree